Amedica Financials

Amedica Stock Summary

Amedica competes with BBB Foods, Parker Hannifin, Western Copper, Summit Materials, and Barrick Gold. Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Amedica operates under Medical Devices classification in USA and is traded on Nasdaq Capital Markets. It employs 33 people.

Amedica Key Financial Ratios

Generally speaking, Amedica's financial ratios allow both analysts and investors to convert raw data from Amedica's financial statements into concise, actionable information that can be used to evaluate the performance of Amedica over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amedica reports annually and quarterly.

Amedica Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amedica's current stock value. Our valuation model uses many indicators to compare Amedica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amedica competition to find correlations between indicators driving Amedica's intrinsic value. More Info.Amedica is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amedica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amedica's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amedica's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Amedica information on this page should be used as a complementary analysis to other Amedica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

If you are still planning to invest in Amedica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedica's history and understand the potential risks before investing.